The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...

Merck (NYSE:MRK) received European Commission approval for KEYTRUDA plus Padcev as a perioperative therapy for resectable ...

On October 14, the U.S. Food and Drug Administration announced that Anktiva (nogapendekin alfa inbakicept-pmln), used ...

ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its lead oncolytic ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

A hospital-based case-control study of 120 bladder cancer patients and 120 matched controls found adjusted associations ...

"Let's perform a urine cytology test" Have you ever been told this when visiting a urologist? You have likely experienced a ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...

A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care. The research, ...

Bladder cancer is one of the most common cancer types in the U.S., according to the National Cancer Institute. It's also one of the most likely types of cancer to recur. Experts are developing ways to ...

Veteran "Young and the Restless" actor Eric Braeden recently disclosed he has bladder cancer and detailed his diagnosis and immunotherapy treatment. "I hate to be this personal, but I think this may ...